Cyclosporin-PG gel - Zhaoke Guangzhou Ophthalmology Pharmaceutical
Alternative Names: CsA-PG Ophthalmic Gel - Zhaoke (Guangzhou) Ophthalmology Pharmaceutical LimitedLatest Information Update: 30 May 2025
At a glance
- Originator Zhaoke Guangzhou Ophthalmology Pharmaceutical
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Dry eyes
Most Recent Events
- 29 Apr 2025 Preclinical trials in Dry eyes in China (Ophthalmic) (NCT06942793)
- 29 Apr 2025 Zhaoke (Guangzhou) Ophthalmology Pharmaceutical plans a phase III trial for Dry eyes in China (Ophthalmic, Gel) in May 2025(NCT06942793)